Your browser doesn't support javascript.
loading
Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies.
Boulter, Alexis C; Maurer, Barry J; Pogue, Meredith; Kang, Min H; Cho, Hwangeui; Knight, Amanda; Reynolds, C Patrick; Quick, Donald; Awasthi, Sanjay; Gerber, David E.
Afiliación
  • Boulter AC; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
  • Maurer BJ; Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX, USA.
  • Pogue M; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
  • Kang MH; Division of Hematology-Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, USA.
  • Cho H; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
  • Knight A; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
  • Reynolds CP; Jeonbuk National University, Jeonju, South Korea.
  • Quick D; South Plains Oncology Consortium, Lubbock, TX, USA.
  • Awasthi S; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
  • Gerber DE; South Plains Oncology Consortium, Lubbock, TX, USA.
Cancer Chemother Pharmacol ; 92(2): 97-105, 2023 08.
Article en En | MEDLINE | ID: mdl-37199745
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Hipertrigliceridemia / Fenretinida / Neoplasias / Antineoplásicos Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Hipertrigliceridemia / Fenretinida / Neoplasias / Antineoplásicos Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos